Arca
Skip to content
Tools
Tools

Tonsillitis

Drug research and approvals for tonsillitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 14 studies of tonsillitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.

  • Recruiting worldwide: 14
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest start dates first, of 14 recruiting on ClinicalTrials.gov ↗

Drug pipeline

10 approved, 2 in phase 3, 12 in phase 2, 1 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Amoxicillin, Telithromycin, Azithromycin, Cefaclor anhydrous, Cefuroxime axetil, Cefprozil anhydrous, (e)-, Cefdinir, Cefixime, Cefditoren pivoxil, Clarithromycin

Penicillin g
Phase 3 Bacterial penicillin-binding protein inhibitor
Mikamycin
Phase 3
Acetaminophen
Phase 2 Cyclooxygenase inhibitor
Celecoxib
Phase 2 Cyclooxygenase-2 inhibitor
Ketorolac
Phase 2 Cyclooxygenase inhibitor
Midazolam
Phase 2 GABA-A receptor; anion channel positive allosteric modulator
Morphine
Phase 2 Mu opioid receptor agonist
Ondansetron
Phase 2 Serotonin 3a (5-HT3a) receptor antagonist
Dexamethasone
Phase 2 Glucocorticoid receptor agonist
Sevoflurane
Phase 2 Glycine receptor (alpha-1/beta) positive modulator
Propofol
Phase 2 GABA-A receptor; anion channel positive allosteric modulator
Fospropofol
Phase 2 Unknown
Oxygen
Phase 2 Essential for cellular homeostasis
Lactic acid
Phase 1 pH lowering agent

How its trials ended

98 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 19 whose ending is known, 47% met their primary endpoint, 0% missed it and 53% stopped early.

  • Completed, result not reported4142%
  • Status unknown2424%
  • Ongoing1414%
  • Met its primary endpoint99%
  • Stopped: sponsor or business decision55%
  • Stopped: other or unclear44%
  • Stopped: enrollment or feasibility11%

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.